MT10109L in the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
Public ClinicalTrials.gov record NCT03732833. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Study to Evaluate the Safety and Efficacy of MT10109L (NivobotulinumtoxinA) for the Treatment of Lateral Canthal Lines With or Without Concurrent Treatment of Glabellar Lines
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
To evaluate the safety and efficacy of MT10109L for the treatment of lateral canthal lines (LCL) with or without concurrent treatment of glabellar lines (GL) in participants with moderate to severe LCL and GL.
Study identification
- NCT ID
- NCT03732833
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 425 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Nov 5, 2018 (Actual)
- Primary completion
- Mar 5, 2020 (Actual)
- Completion
- Jan 25, 2021 (Actual)
- Last update posted
- Jul 17, 2023
2018 – 2021
United States locations
- U.S. sites
- 11
- U.S. states
- 8
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clear Dermatology & Aesthetics Center | Scottsdale | Arizona | 85255-4134 | — |
| Art of Skin MD | Solana Beach | California | 92075-2228 | — |
| Susan H. Weinkle, MD | Bradenton | Florida | 34209-5642 | — |
| Etre Cosmetic Dermatology and Laser Center | New Orleans | Louisiana | 70130-4353 | — |
| Dermatology and Laser Surgery Center of New York | New York | New York | 10028 | — |
| Skin Search of Rochester Inc. | Rochester | New York | 14623 | — |
| M3 Wake Research Inc. | Raleigh | North Carolina | 27612-8106 | — |
| Wilmington Dermatology Center | Wilmington | North Carolina | 28403 | — |
| Aventiv Research Inc. | Dublin | Ohio | 43016 | — |
| Westlake Dermatology & Cosmetic Surgery - Westlake | Austin | Texas | 78746-4720 | — |
| DermResearch Inc. | Austin | Texas | 78759 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 9 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03732833, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jul 17, 2023 · Synced Oct 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT03732833 live on ClinicalTrials.gov.